| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |